Top Markets
#1 Black Phoenix Black Phoenix +167.29%
#2 Islamic Coin Islamic Coin +158.02%
#3 Glidr Glidr +84.34%
#4 Acurast Acurast +40.77%
#5 Cryptopia Cryptopia +21.79%
#6 Quantum Resistant Ledger Quantum Resistant Ledger +18.71%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.57%
#8 wojak wojak +13.88%
#9 Playnance Playnance +13.30%
#10 Test Test +11.66%
Coin of the day
Black Phoenix Black Phoenix
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
DNAPrint Genomics, Inc. DNAPrint Genomics, Inc.

DNAPrint Genomics, Inc.

DNAG
Classifica tra le azioni #41684
DNAPrint Genomics, Inc. focuses on pioneering and distributing genetic analysis... DNAPrint Genomics, Inc. focuses on pioneering and distributing genetic analysis solutions and services. Their product portfolio includes AncestryByDNA, a comprehensive chromosomal assay for tracing genetic lineage, and EurasianDNA, designed to identify specific European ancestral subdivisions. They also offer EuropeanDNA, which outlines an individual's fundamental continental European heritage. In forensic science, DNAWitness assists in determining genetic background from crime scene samples, while RETINOME is utilized by detectives to construct physical traits, such as eye color, from DNA evidence or human remains. Furthermore, the company provides the GenomeLab SNPstream Genotyping System, recognized for its high genotyping throughput, multiplexing capabilities, and efficient reagent usage. DNAPrint Genomics caters to diverse clients in fields like forensic investigation, genealogical exploration, consumer products, and pharmaceutical research. Originally incorporated in 1983 as Lexington Energy, Inc., the company operates from Sarasota, Florida, with an international presence through a subsidiary in Leverkusen, Germany.
Prezzo delle azioni
$0.00002
Ultima sincronizzazione: 2026-08-11
Capitalizzazione di mercato
$12.89K
Variazione (1 giorno)
0.00%
Variazione (1 anno)
100.00%
Paese
US
Scambia DNAPrint Genomics, Inc. (DNAG)

Categoria

Healthcare
Rapporto P/B per DNAPrint Genomics, Inc. (DNAG)
Rapporto P/B al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di DNAPrint Genomics, Inc., il rapporto P/B attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/B per DNAPrint Genomics, Inc. da 2026 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
Non abbastanza dati per le date fornite.
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 -
BE